{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T03:16:59Z","timestamp":1794367019316,"version":"4.9.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,5,9]],"date-time":"2019-05-09T00:00:00Z","timestamp":1557360000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Am J Clin Dermatol"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1007\/s40257-019-00442-w","type":"journal-article","created":{"date-parts":[[2019,5,9]],"date-time":"2019-05-09T07:17:23Z","timestamp":1557386243000},"page":"503-513","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Is There a Role for Antiandrogen Therapy for Hidradenitis Suppurativa? A Systematic Review of Published Data"],"prefix":"10.1007","volume":"20","author":[{"given":"Georgios","family":"Nikolakis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanassios","family":"Kyrgidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos C.","family":"Zouboulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,9]]},"reference":[{"key":"442_CR1","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1111\/j.1600-0625.2008.00712.x","volume":"17","author":"H Kurzen","year":"2008","unstructured":"Kurzen H, Kurokawa I, Jemec GBE, Emtestam L, Sellheyer K, Giamarellos-bourboulis EJ, et al. What causes hidradenitis suppurativa? Exp Dermatol. 2008;17:455\u20136.","journal-title":"Exp Dermatol."},{"key":"442_CR2","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1159\/000431175","volume":"231","author":"CC Zouboulis","year":"2015","unstructured":"Zouboulis CC, Del Marmol V, Mrowietz U, Prens EP, Tzellos T, Jemec GBE. Hidradenitis suppurativa\/acne inversa: criteria for diagnosis, severity assessment, classification and disease evaluation. Dermatology. 2015;231:184\u201390.","journal-title":"Dermatology."},{"key":"442_CR3","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1111\/bjd.15748","volume":"177","author":"CC Zouboulis","year":"2017","unstructured":"Zouboulis CC, Tzellos T, Kyrgidis A, Jemec GBE, Bechara FG, Giamarellos-Bourboulis EJ, et al. Development and validation of the International Hidradenitis Suppurativa Severity Score System (IHS4), a novel dynamic scoring system to assess HS severity. Br J Dermatol. 2017;177:1401\u20139.","journal-title":"Br J Dermatol."},{"key":"442_CR4","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.jaad.2008.06.020","volume":"59","author":"JE Revuz","year":"2008","unstructured":"Revuz JE, Canoui-Poitrine F, Wolkenstein P, Viallette C, Gabison G, Pouget F, et al. Prevalence and factors associated with hidradenitis suppurativa: results from two case-control studies. J Am Acad Dermatol. 2008;59:596\u2013601.","journal-title":"J Am Acad Dermatol."},{"key":"442_CR5","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s40265-015-0516-5","volume":"76","author":"IE Deckers","year":"2016","unstructured":"Deckers IE, Prens EP. An update on medical treatment options for hidradenitis suppurativa. Drugs. 2016;76:215\u201329.","journal-title":"Drugs."},{"key":"442_CR6","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1111\/j.1365-2133.1995.tb02624.x","volume":"133","author":"RL Attanoos","year":"1995","unstructured":"Attanoos RL, Appleton MAC, Douglas-Jones AG. The pathogenesis of hidradenitis suppurativa: a closer look at apocrine and apoeccrine glands. Br J Dermatol. 1995;133:254\u20138.","journal-title":"Br J Dermatol."},{"key":"442_CR7","doi-asserted-by":"publisher","first-page":"125","DOI":"10.2310\/7750.2007.00019","volume":"11","author":"JN Kraft","year":"2007","unstructured":"Kraft JN, Searles GE. Hidradenitis suppurativa in 64 female patients: retrospective study comparing oral antibiotics and antiandrogen therapy. J Cutan Med Surg. 2007;11:125\u201331.","journal-title":"J Cutan Med Surg."},{"key":"442_CR8","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1111\/bjd.14418","volume":"174","author":"JR Ingram","year":"2016","unstructured":"Ingram JR, Woo PN, Chua SL, Ormerod AD, Desai N, Kai AC, et al. Interventions for hidradenitis suppurativa: a Cochrane systematic review incorporating GRADE assessment of evidence quality. Br J Dermatol. 2016;174:970\u20138.","journal-title":"Br J Dermatol."},{"key":"442_CR9","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1177\/1203475417716117","volume":"21","author":"A Alavi","year":"2017","unstructured":"Alavi A, Lynde C, Alhusayen R, Bourcier M, Delorme I, George R, et al. Approach to the management of patients with hidradenitis suppurativa: a consensus document. J Cutan Med Surg. 2017;21:513\u201324.","journal-title":"J Cutan Med Surg."},{"key":"442_CR10","first-page":"1","volume":"19","author":"N Scheinfeld","year":"2013","unstructured":"Scheinfeld N. Hidradenitis suppurativa: a practical review of possible medical treatments based on over 350 hidradenitis patients. Dermatol Online J. 2013;19:1.","journal-title":"Dermatol Online J."},{"key":"442_CR11","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.det.2015.08.005","volume":"34","author":"I Karagiannidis","year":"2016","unstructured":"Karagiannidis I, Nikolakis G, Zouboulis CC. Endocrinologic aspects of hidradenitis suppurativa. Dermatol Clin. 2016;34:45\u20139.","journal-title":"Dermatol Clin."},{"key":"442_CR12","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1002\/bjs.6569","volume":"96","author":"MG Buimer","year":"2009","unstructured":"Buimer MG, Wobbes T, Klinkenbijl JHG. Hidradenitis suppurativa. Br J Surg. 2009;96:350\u201360.","journal-title":"Br J Surg."},{"key":"442_CR13","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1046\/j.1525-1470.1999.00077.x","volume":"16","author":"YM Mengesha","year":"1999","unstructured":"Mengesha YM, Holcombe TC, Hansen RC. Prepubertal hidradenitis suppurativa: two case reports and review of the literature. Pediatr Dermatol. 1999;16:292\u20136.","journal-title":"Pediatr Dermatol."},{"key":"442_CR14","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/s40272-014-0091-3","volume":"16","author":"PR Mikkelsen","year":"2014","unstructured":"Mikkelsen PR, Jemec GBE. Hidradenitis suppurativa in children and adolescents: a review of treatment options. Pediatr Drugs. 2014;16:483\u20139.","journal-title":"Pediatr Drugs."},{"key":"442_CR15","first-page":"239","volume":"24","author":"PT Riis","year":"2016","unstructured":"Riis PT, Ring HC, Themstrup L, Jemec GB. The role of androgens and estrogens in hidradenitis suppurativa: a systematic review. Acta Dermatovenerol Croat. 2016;24:239\u201349.","journal-title":"Acta Dermatovenerol Croat."},{"key":"442_CR16","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1002\/bjs.1800751011","volume":"75","author":"BJ Harrison","year":"1988","unstructured":"Harrison BJ, Read GF, Hughes LE. Endocrine basis for the clinical presentation of hidradenitis suppurativa. Br J Surg. 1988;75:972\u20135.","journal-title":"Br J Surg."},{"key":"442_CR17","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1111\/j.1365-2133.1996.tb07942.x","volume":"134","author":"JH Barth","year":"1996","unstructured":"Barth JH, Layton AM, Cunliffe WJ. Endocrine factors in pre- and postmenopausal women with hidradenitis suppurativa. Br J Dermatol. 1996;134:1057\u20139.","journal-title":"Br J Dermatol."},{"key":"442_CR18","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.bpobgyn.2014.07.012","volume":"28","author":"GBE Jemec","year":"2014","unstructured":"Jemec GBE, Margesson LJ, Danby FW. Hidradenitis suppurativa. Best Pract Res Clin Obstet Gynaecol. 2014;28:1013\u201327.","journal-title":"Best Pract Res Clin Obstet Gynaecol."},{"key":"442_CR19","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s11154-016-9366-z","volume":"17","author":"I Karagiannidis","year":"2016","unstructured":"Karagiannidis I, Nikolakis G, Sabat R, Zouboulis CC. Hidradenitis suppurativa\/acne inversa: an endocrine skin disorder? Rev Endocr Metab Disord. 2016;17:335\u201341.","journal-title":"Rev Endocr Metab Disord."},{"key":"442_CR20","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1055\/s-2007-961807","volume":"39","author":"CC Zouboulis","year":"2007","unstructured":"Zouboulis CC, Chen WC, Thornton MJ, Qin K, Rosenfield R. Sexual hormones in human skin. Horm Metab Res. 2007;39:85\u201395.","journal-title":"Horm Metab Res."},{"key":"442_CR21","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1136\/bmj.298.6665.28","volume":"298","author":"AJ Stellon","year":"1989","unstructured":"Stellon AJ, Wakeling M. Hidradenitis suppurativa associated with use of oral contraceptives. BMJ. 1989;298:28.","journal-title":"BMJ"},{"key":"442_CR22","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1002\/bjs.1800721223","volume":"72","author":"BJ Harrison","year":"1985","unstructured":"Harrison BJ, Kumar S, Read GF, Edwards CA, Scanlon MF, Hughes LE. Hidradenitis suppurativa: evidence for an endocrine abnormality. Br J Surg. 1985;72:1002\u20134.","journal-title":"Br J Surg."},{"key":"442_CR23","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s11154-016-9390-z","volume":"17","author":"G Nikolakis","year":"2017","unstructured":"Nikolakis G, Stratakis CA, Kanaki T, Slominski A, Zouboulis CC. Skin steroidogenesis in health and disease. Rev Endocr Metab Disord. 2017;17:247\u201358.","journal-title":"Rev Endocr Metab Disord."},{"key":"442_CR24","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1080\/09546630510031403","volume":"16","author":"MA Joseph","year":"2005","unstructured":"Joseph MA, Jayaseelan E, Ganapathi B, Stephen J. Hidradenitis suppurativa treated with finasteride. J Dermatol Treat. 2005;16:75\u20138.","journal-title":"J Dermatol Treat."},{"key":"442_CR25","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.jsbmb.2013.02.006","volume":"137","author":"A Slominski","year":"2013","unstructured":"Slominski A, Zbytek B, Nikolakis G, Manna PR, Skobowiat C, Zmijewski M, et al. Steroidogenesis in the skin: implications for local immune functions. J Steroid Biochem Mol Biol. 2013;137:107\u201323.","journal-title":"J Steroid Biochem Mol Biol."},{"key":"442_CR26","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1159\/000363610","volume":"27","author":"R Werner","year":"2014","unstructured":"Werner R, Holterhus P. Androgen action. Endocr Dev. 2014;27:28\u201340.","journal-title":"Endocr Dev."},{"issue":"Suppl. 1","key":"442_CR27","doi-asserted-by":"publisher","first-page":"S60","DOI":"10.1111\/j.1610-0387.2009.07171.x","volume":"8","author":"CC Zouboulis","year":"2010","unstructured":"Zouboulis CC, Rabe T. Hormonal antiandrogens in acne treatment. J Dtsch Dermatol Ges. 2010;8(Suppl. 1):S60\u201374 (in German).","journal-title":"J Dtsch Dermatol Ges."},{"key":"442_CR28","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1111\/jdv.12966","volume":"29","author":"CC Zouboulis","year":"2015","unstructured":"Zouboulis CC, Desai N, Emtestam L, Hunger RE, Ioannides D, Juh\u00e1sz I, et al. European S1 guideline for the treatment of hidradenitis suppurativa\/acne inversa. J Eur Acad Dermatol Venereol. 2015;29:619\u201344.","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"442_CR29","doi-asserted-by":"publisher","first-page":"e31810","DOI":"10.1371\/journal.pone.0031810","volume":"7","author":"R Sabat","year":"2012","unstructured":"Sabat R, Chanwangpong A, Schneider-Burrus S, Metternich D, Kokolakis G, Kurek A, et al. Increased prevalence of metabolic syndrome in patients with acne inversa. PLoS One. 2012;7:e31810.","journal-title":"PLoS One."},{"key":"442_CR30","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1111\/bjd.13777","volume":"173","author":"G Shalom","year":"2015","unstructured":"Shalom G, Freud T, Harman-Boehm I, Polishchuk I, Cohen AD. Hidradenitis suppurativa and metabolic syndrome: a comparative cross-sectional study of 3207 patients. Br J Dermatol. 2015;173:464\u201370.","journal-title":"Br J Dermatol."},{"key":"442_CR31","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1046\/j.1468-3083.2000.00087.x","volume":"14","author":"JM Von Der Werth","year":"2000","unstructured":"Von Der Werth JM, Williams HC. The natural history of hidradenitis suppurativa. J Eur Acad Dermatol Venereol. 2000;14:389\u201392.","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"442_CR32","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1111\/j.1365-2133.1986.tb05741.x","volume":"115","author":"RS Sawers","year":"1986","unstructured":"Sawers RS, Randall VA, Ebling FJG. Control of hidradenitis suppurativa in women using combined antiandrogen (cyproterone-acetate) and estrogen therapy. Br J Dermatol. 1986;115:269\u201374.","journal-title":"Br J Dermatol."},{"key":"442_CR33","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1111\/j.1365-2133.1986.tb05740.x","volume":"115","author":"PS Mortimer","year":"1986","unstructured":"Mortimer PS, Dawber RPR, Gales MA, Moore RA. A double-blind controlled cross-over trial of cyproterone acetate in females with hidradenitis suppurativa. Br J Dermatol. 1986;115:263\u20138.","journal-title":"Br J Dermatol."},{"key":"442_CR34","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/0022-4731(86)90320-1","volume":"25","author":"F Neumann","year":"1986","unstructured":"Neumann F, T\u00f6pert M. Pharmacology of antiandrogens. J Steroid Biochem. 1986;25:885\u201395.","journal-title":"J Steroid Biochem."},{"key":"442_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1055\/s-0028-1093574","volume":"9","author":"F Neumann","year":"1977","unstructured":"Neumann F. Pharmacology and potential use of cyproterone acetate. Horm Metab Res. 1977;9:1\u201313.","journal-title":"Horm Metab Res."},{"key":"442_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1055\/s-0029-1211261","volume":"102","author":"F Neumann","year":"1994","unstructured":"Neumann F. The antiandrogen cyproterone acetate: discovery, chemistry, basic pharmacology, clinical use and tool in basic research. Exp Clin Endocrinol. 1994;102:1\u201332.","journal-title":"Exp Clin Endocrinol."},{"key":"442_CR37","doi-asserted-by":"publisher","first-page":"59","DOI":"10.2165\/00002512-199405010-00006","volume":"5","author":"LB Barradell","year":"1994","unstructured":"Barradell LB, Faulds D. Cyproterone: a review of its pharmacology and therapeutic efficacy in prostate cancer. Drugs Aging. 1994;5:59\u201380.","journal-title":"Drugs Aging."},{"key":"442_CR38","first-page":"455","volume":"168","author":"E Wooltorton","year":"2003","unstructured":"Wooltorton E. Diane-35 (cyproterone acetate): safety concerns. CMAJ. 2003;168:455\u20136.","journal-title":"CMAJ."},{"key":"442_CR39","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1159\/000053267","volume":"54","author":"CE Orfanos","year":"2000","unstructured":"Orfanos CE, Adler YD, Zouboulis CC. The SAHA syndrome. Horm Res Paediatr. 2000;54:251\u20138.","journal-title":"Horm Res Paediatr."},{"key":"442_CR40","doi-asserted-by":"publisher","first-page":"283","DOI":"10.2165\/11631880-000000000-00000","volume":"13","author":"R Alhusayen","year":"2012","unstructured":"Alhusayen R, Shear NH. Pharmacologic interventions for hidradenitis suppurativa: what does the evidence say? Am J Clin Dermatol. 2012;13:283\u201391.","journal-title":"Am J Clin Dermatol."},{"key":"442_CR41","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1111\/ajd.12362","volume":"56","author":"A Lee","year":"2015","unstructured":"Lee A, Fischer G. A case series of 20 women with hidradenitis suppurativa treated with spironolactone. Australas J Dermatol. 2015;56:192\u20136.","journal-title":"Australas J Dermatol."},{"key":"442_CR42","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.jaad.2018.06.063","volume":"80","author":"NM Golbari","year":"2019","unstructured":"Golbari NM, Porter ML, Kimball AB. Antiandrogen therapy with spironolactone for the treatment of hidradenitis suppurativa. J Am Acad Dermatol. 2019;80:114\u20139.","journal-title":"J Am Acad Dermatol"},{"key":"442_CR43","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1007\/s00105-013-2597-y","volume":"64","author":"CM Salavastru","year":"2013","unstructured":"Salavastru CM, Fritz K, Tiplica GS. Spironolacton in dermatologischen Behandlungen: \u201con-label-\u201d und Off-label-Indikationen. Hautarzt. 2013;64:762\u20137.","journal-title":"Hautarzt."},{"key":"442_CR44","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1111\/j.1365-2133.1993.tb03174.x","volume":"129","author":"F Lewis","year":"1993","unstructured":"Lewis F, Messenger AG, Wales JK. Hidradenitis suppurativa as a presenting feature of premature adrenarche. Br J Dermatol. 1993;129:447\u20138.","journal-title":"Br J Dermatol."},{"key":"442_CR45","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1067\/mjd.2000.105557","volume":"43","author":"JC Shaw","year":"2000","unstructured":"Shaw JC. Low-dose adjunctive spironolactone in the treatment of acne in women: a retrospective analysis of 85 consecutively treated patients. J Am Acad Dermatol. 2000;43:498\u2013502.","journal-title":"J Am Acad Dermatol."},{"key":"442_CR46","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1159\/000339477","volume":"224","author":"C Dom\u00e9nech","year":"2012","unstructured":"Dom\u00e9nech C, Matarredona J, Escribano-Stabl\u00e9 JC, Devesa JP, Vicente J, Ja\u00e9n A. Facial hidradenitis suppurativa in a 28-year-old male responding to finasteride. Dermatology. 2012;224:307\u20138.","journal-title":"Dermatology."},{"key":"442_CR47","first-page":"41","volume":"32","author":"P Yl\u00f6stalo","year":"1987","unstructured":"Yl\u00f6stalo P, Heikkinen J, Kauppila A, Pakarinen A, J\u00e4rvinen PA. Low-dose spironolactone in the treatment of female hirsutism. Int J Fertil. 1987;32:41\u20135.","journal-title":"Int J Fertil."},{"key":"442_CR48","doi-asserted-by":"publisher","first-page":"285","DOI":"10.3949\/ccjm.57.3.285","volume":"57","author":"DC Cumming","year":"1990","unstructured":"Cumming DC. Use of spironolactone in treatment of hirsutism. Cleve Clin J Med. 1990;57:285\u20137.","journal-title":"Cleve Clin J Med."},{"key":"442_CR49","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1111\/pde.13216","volume":"34","author":"F Mota","year":"2017","unstructured":"Mota F, Machado S, Selores M. Hidradenitis suppurativa in children treated with finasteride: a case series. Pediatr Dermatol. 2017;34:578\u201383.","journal-title":"Pediatr Dermatol."},{"key":"442_CR50","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1111\/j.1365-2133.1995.tb02663.x","volume":"133","author":"W Eicheler","year":"1995","unstructured":"Eicheler W, Dreher M, Hoffmann R, Happle R, Aumuller G. Immunohistochemical evidence for differential distribution of 5\u03b1-reductase isoenzymes in human skin. Br J Dermatol. 1995;133:371\u20136.","journal-title":"Br J Dermatol."},{"key":"442_CR51","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1046\/j.1523-1747.2002.00613.x","volume":"119","author":"W Chen","year":"2002","unstructured":"Chen W, Thiboutot D, Zouboulis CC. Cutaneous androgen metabolism: basic research and clinical perspectives. J Investig Dermatol. 2002;119:992\u20131007.","journal-title":"J Investig Dermatol."},{"key":"442_CR52","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1159\/000473873","volume":"3075","author":"BN Khandalavala","year":"2017","unstructured":"Khandalavala BN. A disease-modifying approach for advanced hidradenitis suppurativa (regimen with metformin, liraglutide, dapsone, and finasteride): a case report. Case Rep Dermatol. 2017;3075:70\u20138.","journal-title":"Case Rep Dermatol."},{"key":"442_CR53","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1210\/jcem.84.4.5591","volume":"84","author":"S Venturoli","year":"1999","unstructured":"Venturoli S, Marescalchi O, Colombo FM, Macrelli S, Ravaioli B, Bagnoli A, et al. A prospective randomized trial comparing low dose flutamide, finasteride, ketoconazole, and cyproterone acetate-estrogen regimens in the treatment of hirsutism. J Clin Endocrinol Metab. 1999;84:1304\u201310.","journal-title":"J Clin Endocrinol Metab."},{"key":"442_CR54","doi-asserted-by":"publisher","first-page":"111","DOI":"10.2165\/00003495-199957010-00014","volume":"57","author":"KJ McClellan","year":"1999","unstructured":"McClellan KJ, Markham A. Finasteride: a review of its use in male pattern hair loss. Drugs. 1999;57:111\u201326.","journal-title":"Drugs."},{"key":"442_CR55","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1002\/phar.1612","volume":"35","author":"AK Ali","year":"2015","unstructured":"Ali AK, Heran BS, Etminan M. Persistent sexual dysfunction and suicidal ideation in young men treated with low-dose finasteride: a pharmacovigilance study. Pharmacotherapy. 2015;35:687\u201395.","journal-title":"Pharmacotherapy."},{"key":"442_CR56","first-page":"44","volume":"9","author":"BN Khandalavala","year":"2016","unstructured":"Khandalavala BN, Voutsalath M. Finasteride in hidradenitis suppurativa: a \u201cmale\u201d therapy for a predominantly \u201cfemale\u201d disease. J Clin Aesthet Dermatol. 2016;9:44\u201350.","journal-title":"J Clin Aesthet Dermatol."},{"key":"442_CR57","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1016\/S0022-5347(05)68270-5","volume":"162","author":"JW Overstreet","year":"1999","unstructured":"Overstreet JW, Fuh VL, Gould J, Howards SS, Lieber MM, Hellstrom W, et al. Chronic treatment with finasteride daily does not affect spermatogenesis or semen production in young men. J Urol. 1999;162:1295\u2013300.","journal-title":"J Urol."},{"key":"442_CR58","first-page":"555","volume":"41","author":"JL Roberts","year":"1999","unstructured":"Roberts JL, Fiedler V, Imperato-McGinley J, Whiting D, Olsen E, Shupack J, et al. Clinical dose ranging studies with finasteride, a type 2 5\u03b1-reductase inhibitor, in men with male pattern hair loss. J Am Acad Dermatol. 1999;41:555\u201363.","journal-title":"J Am Acad Dermatol."},{"key":"442_CR59","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1001\/jamadermatol.2013.2874","volume":"149","author":"HK Randhawa","year":"2013","unstructured":"Randhawa HK, Hamilton J, Pope E. Finasteride for the treatment of hidradenitis suppurativa in children and adolescents. JAMA Dermatol. 2013;149:732\u20135.","journal-title":"JAMA Dermatol."},{"key":"442_CR60","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1111\/j.1365-2133.2010.09777.x","volume":"163","author":"ME Gonzalez","year":"2010","unstructured":"Gonzalez ME, Cantatore-Francis J, Orlow SJ. Androgenetic alopecia in the paediatric population: a retrospective review of 57 patients. Br J Dermatol. 2010;163:378\u201385.","journal-title":"Br J Dermatol."},{"key":"442_CR61","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1111\/j.1468-3083.2012.04668.x","volume":"27","author":"R Verdolini","year":"2013","unstructured":"Verdolini R, Clayton N, Smith A, Alwash N, Mannello B. Metformin for the treatment of hidradenitis suppurativa: a little help along the way. J Eur Acad Dermatol Venereol. 2013;27:1101\u20138.","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"442_CR62","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1111\/bjd.13090","volume":"171","author":"CB Kromann","year":"2014","unstructured":"Kromann CB, Deckers IE, Esmann S, Boer J, Prens EP, Jemec GBE. Risk factors, clinical course and long-term prognosis in hidradenitis suppurativa: a cross-sectional study. Br J Dermatol. 2014;171:819\u201324.","journal-title":"Br J Dermatol."},{"key":"442_CR63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/09546634.2018.1529383","volume":"19","author":"EJ Yang","year":"2018","unstructured":"Yang EJ, Beck KM, Bhutani T, Feldman SR, Shi VY. Pharmacy costs of systemic medications for hidradenitis suppurativa in the United States. J Dermatol Treat. 2018;19:1\u20133. \n                    https:\/\/doi.org\/10.1080\/09546634.2018.1529383\n                    \n                  \n                           (Epub ahead of print).","journal-title":"J Dermatol Treat"},{"key":"442_CR64","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1111\/j.1610-0387.2012.08006.x","volume":"10","author":"CC Zouboulis","year":"2012","unstructured":"Zouboulis CC, Bechara FG, Fritz K, Kurzen H, Liakou AI, Marsch WC, et al. S1 guideline for for the treatment of hidradenitis suppurativa\/acne inversa* (number ICD-10 L73.2). J Dtsch Dermatol Ges. 2012;10:S1\u201331 (in German).","journal-title":"J Dtsch Dermatol Ges"}],"container-title":["American Journal of Clinical Dermatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-019-00442-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40257-019-00442-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-019-00442-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,7]],"date-time":"2020-05-07T23:10:42Z","timestamp":1588893042000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40257-019-00442-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,9]]},"references-count":64,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["442"],"URL":"https:\/\/doi.org\/10.1007\/s40257-019-00442-w","relation":{},"ISSN":["1175-0561","1179-1888"],"issn-type":[{"value":"1175-0561","type":"print"},{"value":"1179-1888","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,9]]},"assertion":[{"value":"9 May 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"This work was an investigator-initiated project and was not supported by any financial means.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Christos C. Zouboulis has received honoraria from AbbVie for participation as an advisor and speaker, and from Idorsia, Inflarx, Novartis, and UCB for participation as an advisor. His department has received grants from AbbVie, Inflarx, Novartis, and UCB for his participation as an investigator. Georgios Nikolakis and Athanassios Kyrgidis have no conflicts of interest that are directly relevant to the content of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}